Tag: long-acting rFVIII (BAY 94-9027)
Bayer to invest more than 500 million euros for haemophilia A products manufacturing
Bayer, Germany’s biggest pharmaceutical company, has announced that it will invest more than 500 million euros in its Wuppertal and Leverkusen manufacturing sites to...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
